Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer

Conditions:   Medullary Thyroid Carcinoma;   Multiple Endocrine Neoplasia Type 2A;   Multiple Endocrine Neoplasia Type 2BIntervention:   Drug: VandetanibSponsors:   National Cancer Institute (NCI);   National Institutes of Health Clinical Center (CC)Active, not recruiting - verified October 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials